1. Home
  2. ATCH vs VTAK Comparison

ATCH vs VTAK Comparison

Compare ATCH & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATCH
  • VTAK
  • Stock Information
  • Founded
  • ATCH 2022
  • VTAK 2002
  • Country
  • ATCH United States
  • VTAK United States
  • Employees
  • ATCH N/A
  • VTAK N/A
  • Industry
  • ATCH
  • VTAK Medical/Dental Instruments
  • Sector
  • ATCH
  • VTAK Health Care
  • Exchange
  • ATCH Nasdaq
  • VTAK Nasdaq
  • Market Cap
  • ATCH 3.2M
  • VTAK 3.1M
  • IPO Year
  • ATCH N/A
  • VTAK 2018
  • Fundamental
  • Price
  • ATCH $0.18
  • VTAK $0.23
  • Analyst Decision
  • ATCH
  • VTAK
  • Analyst Count
  • ATCH 0
  • VTAK 0
  • Target Price
  • ATCH N/A
  • VTAK N/A
  • AVG Volume (30 Days)
  • ATCH 1.6M
  • VTAK 1.4M
  • Earning Date
  • ATCH 08-27-2025
  • VTAK 08-13-2025
  • Dividend Yield
  • ATCH N/A
  • VTAK N/A
  • EPS Growth
  • ATCH N/A
  • VTAK N/A
  • EPS
  • ATCH 2.67
  • VTAK N/A
  • Revenue
  • ATCH N/A
  • VTAK $481,000.00
  • Revenue This Year
  • ATCH N/A
  • VTAK $822.86
  • Revenue Next Year
  • ATCH N/A
  • VTAK $168.42
  • P/E Ratio
  • ATCH $0.07
  • VTAK N/A
  • Revenue Growth
  • ATCH N/A
  • VTAK 9.57
  • 52 Week Low
  • ATCH $0.17
  • VTAK $0.16
  • 52 Week High
  • ATCH $39.00
  • VTAK $3.05
  • Technical
  • Relative Strength Index (RSI)
  • ATCH 38.48
  • VTAK 44.34
  • Support Level
  • ATCH $0.18
  • VTAK $0.22
  • Resistance Level
  • ATCH $0.21
  • VTAK $0.24
  • Average True Range (ATR)
  • ATCH 0.01
  • VTAK 0.01
  • MACD
  • ATCH 0.00
  • VTAK -0.00
  • Stochastic Oscillator
  • ATCH 24.32
  • VTAK 11.00

About ATCH AtlasClear Holdings Inc. Common Stock

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and innovative financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

Share on Social Networks: